Metraipolis › archive › dc_a228caa3209e

Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study — Europe PMC PMID:29159517

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/29159517
DOI
10.1007/s12282-017-0815-7
License (as archived)
solo-consultazione
Archived
2026-10-10T00:27:54.731Z
SHA-256 of the archived text
b26960296bbaaa7d982a897e21eead59a163af193538ee5bc494a71fb6680f3a
Stable URL of this page
https://metraipolis.com/documento/dc_a228caa3209e

How to cite

Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study — Europe PMC PMID:29159517 — Europe PMC (en), https://europepmc.org/article/MED/29159517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a228caa3209e (Metraipolis archive dc_a228caa3209e, sha256 b26960296bbaaa7d982a897e21eead59a163af193538ee5bc494a71fb6680f3a)
BibTeX
@misc{dca228caa3209e,
  title = {Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study — Europe PMC PMID:29159517},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/29159517},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a228caa3209e; sha256 b26960296bbaaa7d982a897e21eead59a163af193538ee5bc494a71fb6680f3a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/29159517. Agents can read the archived copy with the MCP tool read_document.